ciprofloxacin has been researched along with Communicable Diseases in 10 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Communicable Diseases: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofloxacin is a broad spectrum fluoroquinolone antibacterial agent." | 2.39 | Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability. ( Balfour, JA; Davis, R; Markham, A, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Turaihi, TSA | 1 |
| Mubark, HA | 1 |
| Hadi, ZJ | 1 |
| Akool, MA | 1 |
| Al-Nafak, RT | 1 |
| Yedle, R | 1 |
| Reniguntla, MK | 1 |
| Puttaswamy, R | 1 |
| Puttarangappa, P | 1 |
| Hiremath, S | 1 |
| Nanjundappa, M | 1 |
| Jayaraman, R | 1 |
| Edson, RS | 1 |
| Litin, SC | 1 |
| Bundrick, JB | 1 |
| Lorenzana, N | 1 |
| Avila, LF | 1 |
| Alonso, S | 1 |
| Colado, E | 1 |
| Bernal, T | 1 |
| Welling, M | 1 |
| Stokkel, M | 1 |
| Balter, J | 1 |
| Sarda-Mantel, L | 1 |
| Meulemans, A | 1 |
| Le Guludec, D | 1 |
| Davis, R | 1 |
| Markham, A | 1 |
| Balfour, JA | 1 |
| Ivanov, RN | 1 |
| Salazar, R | 1 |
| Solá, C | 1 |
| Maroto, P | 1 |
| Tabernero, JM | 1 |
| Brunet, J | 1 |
| Verger, G | 1 |
| Valentí, V | 1 |
| Cancelas, JA | 1 |
| Ojeda, B | 1 |
| Mendoza, L | 1 |
| Rodríguez, M | 1 |
| Montesinos, J | 1 |
| López-López, JJ | 1 |
| Engels, EA | 1 |
| Ellis, CA | 1 |
| Supran, SE | 1 |
| Schmid, CH | 1 |
| Barza, M | 1 |
| Schenkein, DP | 1 |
| Koc, Y | 1 |
| Miller, KB | 1 |
| Wong, JB | 1 |
| Frisolone, J | 1 |
| Ostrosky, J | 1 |
| Symes, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Drug Utilization Evaluation Study of Ciprofloxacin Utilization and Adverse Events Occurrence in Community Pharmacy Setting: A Cross-Sectional Study[NCT05916105] | 151 participants (Actual) | Observational | 2021-09-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for ciprofloxacin and Communicable Diseases
| Article | Year |
|---|---|
Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.
Topics: Anti-Infective Agents; Ciprofloxacin; Communicable Diseases; Drug Interactions; Drug Tolerance; Econ | 1996 |
9 other studies available for ciprofloxacin and Communicable Diseases
| Article | Year |
|---|---|
ANTIBIOTIC RESISTANCE OF SALMONELLA TYPHI CARRIER ASSOCIATED WITH GALL BLADDER CHRONIC INFECTION IN AL-NAJAF PROVINCE.
Topics: Ampicillin; Anti-Bacterial Agents; Cefepime; Cefixime; Chloramphenicol; Ciprofloxacin; Communicable | 2023 |
Neutropenic Rat Thigh Infection Model for Evaluation of the Pharmacokinetics/Pharmacodynamics of Anti-Infectives.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Communicable Disease | 2023 |
Clinical Pearls in Infectious Diseases 2017.
Topics: Administration, Intravaginal; Adult; Aged; Anti-Bacterial Agents; Body Piercing; Campylobacter Infec | 2017 |
The impact of antimicrobial prophylaxis in morbidity and infections during azacitidine treatment.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Antimetabolites, Antineo | 2017 |
The many roads to infection imaging.
Topics: Ciprofloxacin; Communicable Diseases; Diagnostic Imaging; Humans; Molecular Probe Techniques; Sensit | 2008 |
[The use of Ciprobay in the infectious complications of traumatic illness].
Topics: Anti-Infective Agents; Ciprofloxacin; Communicable Diseases; Humans; Wounds and Injuries | 1997 |
Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
Topics: Acyclovir; Adolescent; Adult; Anti-Infective Agents; Antifungal Agents; Antineoplastic Combined Chem | 1999 |
Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk.
Topics: Adult; Anti-Bacterial Agents; Bone Marrow Transplantation; Ciprofloxacin; Communicable Diseases; Fem | 1999 |
Criteria for use of ciprofloxacin for infections in adult patients.
Topics: Adult; Ciprofloxacin; Communicable Diseases; Drug Evaluation; Humans; Information Services; Middle A | 1990 |